SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank11
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P11
Within normal range
vs 5Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-37.07%
Q3 2025-71.28%
Q2 2025162.98%
Q1 2025-45.89%
Q4 202422.39%
Q3 202462.93%
Q2 2024-36.47%
Q1 202486.74%
Q4 2023-28.40%
Q3 2023-39.33%
Q2 202310.19%
Q1 20230.85%
Q4 202242.63%
Q3 2022-32.25%
Q2 2022-0.94%
Q1 2022-13.33%
Q4 202144.18%
Q3 202110.52%
Q2 202122.88%
Q1 2021-31.99%
Q4 202036.49%
Q3 2020-11.18%
Q2 202053.38%
Q1 2020-10.39%
Q4 2019-33.60%
Q3 201921.15%
Q2 2019-17.26%
Q1 2019205.76%
Q4 20180.00%